Tag: Afra

October 25, 2019

IPL 2020: Ravichandran Ashwin set to join Delhi Capitals

first_img Indo-Asian News Service New DelhiSeptember 4, 2019UPDATED: September 4, 2019 16:53 IST Ravichandran Ashwin has taken 125 wickets in 139 IPL matches. (Reuters Photo)HIGHLIGHTSRavichandran Ashwin is all set to make a switch from Kings XI Punjab to Delhi CapitalsRavichandran Ashwin led KXIP in 14 matches in this year’s IPL editionKings XI are likely to appoint a new captain, with K.L. Rahul being currently the favouriteAce Indian off-spinner Ravichandran Ashwin is all set to make a switch from Kings XI Punjab to Delhi Capitals for next edition of the Indian Premier League (IPL).”Yes, it was a work in progress and we were waiting for the signature of one of the KXIP directors before going ahead with the deal. The team management believes looking at the last season that he can play an integral role on the kind of wickets that we play on at home,” a DC official told IANS.Ashwin, who was signed by Kings XI Punjab at the 2018 auction for Rs 7.6 crore, led the franchise in 14 matches in this year’s IPL edition and scalped 15 wickets.Overall, the off-spinner has taken 125 wickets in 139 IPL matches at an economy rate of 6.79, which is the best among all Indian bowlers with 50-plus wickets.KXIP have not made the IPL play-offs since 2014 when they finished as runners-up. The Punjab-based franchise has not been able to perform as per expectations ever since IPL’s inaugural season in 2008 and are, along with Delhi, the two franchises, who have not been able to lift the trophy till now.It is also reported that Kings XI are likely to appoint a new captain, with K.L. Rahul being currently the favourite.Former New Zealand head coach Mike Hesson, who was in charge of KXIP in this year’s edition of IPL, last month joined Royal Challengers Bangalore (RCB) as director of Cricket Operations.Delhi Capitals are also in talks with Rajasthan Royals to bring in Ajinkya Rahane to their squad for the next season of the cash-rich league.advertisementFor sports news, updates, live scores and cricket fixtures, log on to indiatoday.in/sports. Like us on Facebook or follow us on Twitter for Sports news, scores and updates.Get real-time alerts and all the news on your phone with the all-new India Today app. Download from Post your comment Do You Like This Story? Awesome! Now share the story Too bad. Tell us what you didn’t like in the comments Posted bySaurabh Kumar Tags :Follow Delhi CapitalsFollow Ravichandran Ashwin IPL 2020: Ravichandran Ashwin set to join Delhi CapitalsRavichandran Ashwin, who was signed by Kings XI Punjab at the 2018 auction for Rs 7.6 crore, led the franchise in 14 matches in this year’s IPL edition and scalped 15 wickets.advertisement Nextlast_img read more

October 24, 2019

‘Logos Hope’ Commences Its Annual Routine …

first_img My location Print  Close zoom Logos Hope is once again out of the water for its annual routine maintenance at Yiu Lian’s floating dry dock in Hong Kong. Work had already begun in the fan room with the renewal of the deck steel where it was badly corroded.Other works will be focused on main engine no. 2 and the auxiliary engine no. 1 overhauls. Many pipes will also need to be renewed; especially in the bulkheads walls of the Hope Theatre.This is the second time Logos Hope has chosen to be in Hong Kong for maintenance.“Last year we had a great experience and so far we have had a great start,” said technical manager Harald Smit (Netherlands). “Hong Kong shipyard workers are friendly, fast and efficient,” he added. Logos Hope is expected to be in the shipyard for one month. GBA Ships, March 21, 2014 此页面无法正确加载 Google 地图。您是否拥有此网站?确定last_img read more

October 22, 2019

Province to Fund Lucentis Treatment

first_imgNova Scotians suffering from Wet Age-Related Macular Degeneration (AMD), a chronic retina disease, will soon have public funding for treatments to prevent and reverse the disease. The province announced today, Oct. 20, coverage for Lucentis treatment of AMD for beneficiaries of publicly funded drug programs such as Senior’s Pharmacare, Family Pharmacare and Community Services Pharmacare programs, effective Jan. 1. “Lucentis is an expensive drug, but by delivering the treatment in hospital-based eye clinics, using retinal specialists, we can improve efficiencies and reduce the budget impact by millions of dollars in the coming years,” said Health Minister Maureen MacDonald. “It is a creative approach and the right decision to provide better health care while living within our means.” The province is also announcing that patients who are currently receiving treatment for AMD with Avastin can also receive publicly funded therapy, if they and their physician wish to do so. Wet Age-Related Macular Degeneration affects the central vision. It can cause blood and fluid to leak into the eye and lead to blindness. It tends to affect people age 50 or older with the vast majority of those affected older than 65. Lucentis and Avastin therapies will be provided to Nova Scotians who meet the clinical criteria. Patients who have private insurance will continue to access those resources. Patients have been paying about $1,800 to $2,000 per injection for Lucentis therapy, usually requiring six or more injections per year. Avastin therapy currently costs patients as much as $500 per injection. “I think the announcement of funding is wonderful news,” said Dr. Alan Cruess, district chief, Capital Health Department of Ophthalmology and Visual Sciences. “Lucentis has the potential to improve vision for people with wet AMD, especially if it’s caught early.” More than 800 Nova Scotians will benefit in the coming year. “These two treatment options will help to maintain the quality of life and independence of hundreds of Nova Scotians every year,” said Duncan Williams, CNIB director of government relations. “This is a wise investment of health dollars that will actually reduce the associated costs of vision loss on families and the province.” “For most Nova Scotians without private health insurance coverage, Lucentis is virtually unaffordable,” said Ms. MacDonald. “This will enable Nova Scotians from all walks of life with wet macular degeneration to access Lucentis.”last_img read more